Literature DB >> 3810155

Evaluation of intrinsic binding energy from a hydrogen bonding group in an enzyme inhibitor.

P A Bartlett, C K Marlowe.   

Abstract

This and two accompanying reports describe the intrinsic binding energy derived from a single hydrogen bond between an inhibitor and an enzyme. The results were obtained by comparing matched pairs of inhibitors of the zinc endopeptidase thermolysin that bind to the enzyme in an essentially identical manner but differ in the presence or absence of a specific hydrogen bond. This report describes five phosphorus-containing analogs of the peptides carbobenzoxy-Gly-Leu-X, in which the Gly-Leu peptide linkage is replaced with a phosphonate ester (-PO2(-)-O-). Values for the inhibition constants of these inhibitors show a direct relation with those of the corresponding phosphonamidate analogs (-PO2(-)-NH- in place of the Gly-Leu peptide moiety), which have been characterized previously as transition state analogs. However, each phosphonate ester is bound about 840 times more weakly than the analogous phosphonamidate, reflecting the loss of 4.0 +/- 0.1 kilocalories per mole in binding energy. From these results and the crystallographic analysis in the next report, it can be inferred that the value of 4.0 kilocalories per mole represents the intrinsic binding energy arising from a highly specific hydrogen binding interaction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3810155     DOI: 10.1126/science.3810155

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  11 in total

1.  Comparative molecular similarity index analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries.

Authors:  G Klebe; U Abraham
Journal:  J Comput Aided Mol Des       Date:  1999-01       Impact factor: 3.686

2.  Contribution of asparagine residues to the stabilization of a proteinaceous antigen-antibody complex, HyHEL-10-hen egg white lysozyme.

Authors:  Akiko Yokota; Kouhei Tsumoto; Mitsunori Shiroishi; Takeshi Nakanishi; Hidemasa Kondo; Izumi Kumagai
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

3.  Towards the automatic design of synthetically accessible protein ligands: peptides, amides and peptidomimetics.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1996-08       Impact factor: 3.686

Review 4.  Domains, motions and regulation in the myosin head.

Authors:  P Vibert; C Cohen
Journal:  J Muscle Res Cell Motil       Date:  1988-08       Impact factor: 2.698

Review 5.  Catalytic antibodies.

Authors:  G M Blackburn; A S Kang; G A Kingsbury; D R Burton
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

6.  Binding of phosphorus-containing inhibitors to thermolysin studied by the Poisson-Boltzmann method.

Authors:  J Shen; J Wendoloski
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

7.  Functional and structural analysis of a key region of the cell wall inhibitor moenomycin.

Authors:  Shinichiro Fuse; Hirokazu Tsukamoto; Yanqiu Yuan; Tsung-Shing Andrew Wang; Yi Zhang; Megan Bolla; Suzanne Walker; Piotr Sliz; Daniel Kahne
Journal:  ACS Chem Biol       Date:  2010-07-16       Impact factor: 5.100

8.  Critical role of a hydrogen bond in the interaction of phospholipase A2 with transition-state and substrate analogues.

Authors:  L Yu; E A Dennis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

9.  A Bacterial Cell Shape-Determining Inhibitor.

Authors:  Yanjie Liu; Emilisa Frirdich; Jennifer A Taylor; Anson C K Chan; Kris M Blair; Jenny Vermeulen; Reuben Ha; Michael E P Murphy; Nina R Salama; Erin C Gaynor; Martin E Tanner
Journal:  ACS Chem Biol       Date:  2016-01-15       Impact factor: 5.100

10.  Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach.

Authors:  Reem Y Aljindan; Abeer M Al-Subaie; Ahoud I Al-Ohali; Thirumal Kumar D; George Priya Doss C; Balu Kamaraj
Journal:  Comput Biol Med       Date:  2021-07-16       Impact factor: 4.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.